导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.39% | 832/1050 |
| 近一周 | -1.93% | 377/1104 |
| 近一月 | -2.79% | 316/1102 |
| 近一季 | 3.09% | 154/1092 |
| 近半年 | -6.78% | 674/1070 |
| 近一年 | -19.42% | 892/1018 |
| 近两年 | 0.83% | 883/926 |
| 近三年 | 0.90% | 672/834 |
| 成立以来 | 38.93% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.61% 990/1070 |
-6.37% 827/1101 |
- - |
- - |
| 2025 | -9.11% 957/1065 |
1.55% 679/1014 |
-5.63% 971/1038 |
1.76% 976/1050 |
-6.80% 787/1065 |
| 2024 | 23.43% 63/1011 |
6.75% 66/960 |
-0.16% 320/983 |
14.27% 275/991 |
1.35% 264/1011 |
| 2023 | 3.30% 58/952 |
3.52% 406/880 |
0.54% 160/895 |
-1.60% 140/915 |
0.87% 98/952 |
| 2022 | -7.02% 50/867 |
-13.66% 206/773 |
15.46% 111/806 |
-9.19% 199/845 |
2.72% 288/867 |
| 2021 | -4.02% 403/740 |
8.01% 18/580 |
14.54% 244/659 |
-23.75% 654/704 |
1.74% 366/740 |
| 2020 | 25.09% 368/554 |
7.18% 55/419 |
16.01% 335/466 |
2.42% 395/517 |
-1.77% 500/554 |
| 2019 | - - |
- - |
- - |
4.46% 210/390 |
7.13% 270/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 宝盈品牌消费股票A VS. 东吴新产业精选股票A(580008) |